Why it matters: This newly published analysis reveals that many CBD products in the UK are misleadingly labeled in terms of their actual CBD content. This raises concerns about the quality of CBD products and highlights the need for improved regulation in the industry.
What they are saying: The researchers assessed various CBD products, including tinctures, oils, e-liquids, and beverages, purchased online in the UK. They found that the measured CBD concentrations in the products fell below the advertised concentrations. Oils deviated the least from the advertised concentrations, while drinks deviated the most. Only 8% of the products had measured concentrations within 10% of the advertised concentrations.
The big picture: The proliferation of CBD products worldwide, including in the US, has outpaced regulation. This lack of regulation leaves consumers uninformed about the contents of the products they are purchasing. Legislation has been reintroduced in the US to place CBD products under the regulatory oversight of the FDA.
What to watch: It will be important to monitor whether improved regulation is implemented for CBD products, both in the UK and globally. Consumers should exercise caution and aware of the potential discrepancies in CBD product labeling.
My take: This analysis highlights significant concerns regarding the quality and accuracy of CBD product labeling. The lack of regulation in the industry is putting consumers at risk. Improved regulation is necessary to ensure that CBD products are accurately labeled and meet quality standards. Consumers should be informed and cautious when purchasing CBD products.
